Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Light instead of darkness: the Argus II implant

Dear Sir or Madam,

Night blindness, restriction of the peripheral visual field and ultimately blindness – this is the course of the hereditary eye disorder Retinitis Pigmentosa. Our current video deals with the Argus II implant, which makes it possible for people with Retinitis Pigmentosa to perceive light and therefore to get a better orientation and which occasionally gives a new lease of life.

Have fun watching,

Olga Wart
Editorial team MEDICA-tradefair.com


MEDICA Trade Fair with Forums and Conferences
Monday to Thursday
13 to 16 November 2017
Düsseldorf, Germany

Table of Contents

Video: Light instead of darkness
Interview: Occupational health management
Newsletter Service
RSS Service
Newsletter Archive

Light instead of darkness – Seeing with the Argus II Implant

Video

Image: Preview picture of video "Light instead of darkness"
Retinitis pigmentosa is a hereditary eye disorder, which can lead to night blindness, restriction of the peripheral visual field and ultimately to blindness. The University Hospital Aachen, Germany, implants the Argus II retinal prosthesis system made by the Second Sight Company. It allows people with retinitis pigmentosa to perceive light and improve orientation.
Click here for the video!
Light instead of darkness – Seeing with the Argus II Implant
See more reports in our MediaCenter!
To top

Research & Technology

Diabetes damages small blood vessels on the heart

Diabetics have a significantly higher risk of suffering a heart attack. A research team at the Technical University of Munich (TUM) has now identified one of the causes: Diabetes is associated with the loss of small blood vessels around the heart. This in turn affects the entire cardiac muscle. A genetic therapy that promotes the growth of blood vessels may offer a remedy.
read more
To top

Research & Technology

A pocket-sized retina camera, no dilating required

It is the part of the eye exam everyone hates: the pupil-dilating eye drops. The drops work by opening the pupil and preventing the iris from constricting in response to light and are often used for routine examination and photography of the back of the eye.
read more
To top

Healthy at work: Occupational health management

Interview

Image: A man beats his hands over his head. To the left and to the right of him, one can see hands that give him things or show the clock; Copyright: panthermedia.net/Dima Sidelnikov
Exercising, keeping fit, staying healthy as you age – modern lifestyle goals pursued by many. Another buzzword related to this lifestyle is work-life balance. But how can you maintain this balance if your job makes it impossible to stay healthy? If stress and physical as well as emotional distress cripple employees? Finding a balance and compensate for these aspects in your leisure time is often barely possible.
Read more in the interview:
Healthy at work: "Occupational health management is a win-win situation"
All interviews at MEDICA-tradefair.com
To top

Public Health & Associations

Delaying school start times won't help sleep deprived teenagers

Delaying school start times in the UK is unlikely to reduce sleep deprivation in teenagers, research from the University of Surrey and Harvard Medical School has found. The research, conducted in collaboration between mathematicians and sleep scientists, predicts that turning down the lights in the evening would be much more effective at tackling sleep deprivation.
read more
To top

Public Health & Associations

'Geofencing' shows promise in tracking chronic care

Location-tracking apps on smartphones could be used to help track and manage care for thousands of patients who suffer from chronic diseases, and possibly even provide feedback to them on lifestyle changes that could help, according to an initial assessment by researchers at UC San Francisco.
read more
To top

Economy & Markets

Pharmacists: greater role in care prevents repeat hospital visits

Pharmacists given an expanded role in patient oversight can reduce the likelihood of high-risk patients returning to the hospital, according to a new study that underscores a potential cost-saving solution for a growing physician shortage.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top

beta-web GmbH - Partner of Messe Düsseldorf

Advertising Opportunities

As an official partner of Messe Düsseldorf, beta-web markets exclusive forms of advertisements to exhibitors of the MEDICA.

You want to be part of the newsletter and reach over 30.000 interested readers with your advertising message? Then contact us at medica@beta-web.de or call us: 0049 – 228 9193735.

For more information on our available forms of advertisements, please see our Media Kit.
Website of beta-web GmbH
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.